IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine
Amount Raised
£11.5 Million
Round Type
Series A
LondonBiotechnology ResearchInvestors
Description
IMU Biosciences announces the close of a £11.5 million Series A financing round, led by European tech VC Molten Ventures and included LifeX Ventures and other individuals. The funding will be deployed to advance its novel CytAtlas® platform, foster new strategic partnerships and projects, conduct cutting-edge large-scale immune research, and expand its operations into the Boston/Cambridge, MA area.
Quick answer
IMU Biosciences raised £11.5 Million in a Series A round, dated January 24, 2024. Investors: Life X Ventures and Molten Ventures. IMU Biosciences is based in London, England, United Kingdom.
- How much did IMU Biosciences raise?
- IMU Biosciences raised £11.5 Million in a Series A round on January 24, 2024.
- Who invested in IMU Biosciences?
- Life X Ventures and Molten Ventures are named as investors in this round.
- What does IMU Biosciences do?
- Mapping the immune system in unprecedented detail and scale.
- Where is IMU Biosciences based and how big is it?
- IMU Biosciences is based in London, England, United Kingdom. Fundz records about 79 employees.
- Who are the decision-makers at IMU Biosciences?
- Fundz holds 2 contacts at IMU Biosciences, including the Co-Founder & COO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology Research around the same time
Companies in the same sectors as IMU Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Baseimmune raised $11M (Series A) on February 26, 2024.
- eFeed raised $10M (Seed) on February 21, 2024.
- VRG Therapeutics raised $15M (Series B) on February 20, 2024.
- Colipi raised $1.9M (Seed) on February 19, 2024.
- FreezeM raised $14M (Series A) on February 15, 2024.
- SingleTimeMicroneedles raised an undisclosed amount (Pre-Seed) on February 14, 2024.
Who to call at IMU Biosciences, and when
A new round usually means IMU Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day IMU Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IMU Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IMU Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IMU Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansIMU Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.